New devices are extending time of euglycemia while reducing risk of hypoglycemia. We recap recent developments and share a remote monitoring initiative from our Center for CardioMetabolic Health.
Targeting the protein hepsin may be a viable option for treating diabetes.
Findings of a high-frequency spinal cord stimulation study may point to an attractive new option for treating the debilitating and painful condition that affects as many as 40% of people with diabetes.
Prompted by the pandemic, the Endocrinology & Metabolism Institute transitioned outpatient visits to telemedicine in a matter of days. In this article, institute leadership discusses the transition and what their practice might look like after COVID-19.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The annual conference, which takes place in Cleveland and Baton Rouge, provide clinicians the latest on the science and treatment of obesity and its comorbidities.
Hospitals seeking to undertake a self-management approach to diabetes care need to draft clear institutional policies. A closer look at results of a Cleveland Clinic study.
Cleveland Clinic’s first total face transplant recipient also faced substantial endocrinological challenges, including pituitary gland dysfunction and diabetes insipidus. Chairman Laurence Kennedy, MD, FRCP, explains how his endocrinology team ensured a good outcome.
More information is needed about disease pathogenesis, response to treatment and how we prevent complications. Cole Eye Institute’s Rishi Singh, MD, reviews research underway.
Following two previous bariatric surgeries elsewhere, a 45-year-old woman undergoes a revision to a distal gastric bypass with outstanding results.
Immunobiology of beta cell failure, genetic diabetes and islet cell therapy are among focal points of our “3rd Annual Beta Cell Symposium” CME course Nov. 9-10.